FDA Interventional Radiological Imaging and Visualization; IRIS Fellowship

How to Apply

To submit your application, scroll to the bottom of this opportunity and click APPLY.

• An application
• Transcripts –  for detailed information about acceptable transcripts
• A current resume/CV, including academic history, employment history, relevant experiences, and publication list
• One educational or professional recommendation

U.S. Food and Drug Administration (FDA)

FDA-CDRH-

3/27/2026 3:00:00 PM Eastern Time Zone

Applications will be reviewed on a rolling‑basis.

A Postdoctoral Fellow opportunity is available immediately with the Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), located in White Oak, Maryland.

The mission of CDRH is to protect and promote public health. CDRH ensures patients and providers have timely and continued access to safe, effective, and high‑quality medical devices and safe radiation‑emitting products. CDRH provides consumers, patients, caregivers, and providers with understandable, science‑based information about the products overseen by CDRH. CDRH facilitates medical device innovation by advancing regulatory science, providing industry with predictable, consistent, transparent, and efficient regulatory pathways, and assuring consumer confidence in devices marketed in the U.S.

The IRIS program addresses regulatory science challenges in interventional and autonomous systems, extended reality technologies, and novel imaging validation and evaluation methodologies. This integrated project aims to develop specialized laboratory capabilities and personnel expertise to evaluate autonomous surgical robotics, mixed reality medical applications, and phantom‑based alternatives. Participants will gain extensive learning opportunities across three critical areas of medical device regulation and will develop performance assessment methods for autonomous interventional systems, testing protocols across multiple technologies, and validation approaches using digital twins and anthropomorphic phantoms to reduce clinical trial burden.

• Hands‑on expertise in AI navigation and robotics systems integration, real‑time imaging technologies, and performance validation protocols.
• Knowledge of optical and x‑ray system calibration, mixed‑reality hardware integration, and evaluation methods for extended reality applications.
• Advanced skills in imaging and navigation test object fabrication using additive manufacturing, tissue‑mimicking material characterization, and multi‑modal imaging protocol evaluation.

Aldo Badano (aldo.badano.gov) and Nirmal Soni (nimral.soni.gov).

• Start Date:
  
  Spring 2026 (flexible)
• Length:
  Initially one year, may be renewed upon recommendation and contingent on available funds
• Level: Full time
• Stipend:
  Monthly, commensurate with educational level and experience

Open to U.S. citizens, Lawful Permanent Residents (LPR), and foreign nationals. Non‑U.S. citizen applicants should refer to the Guidelines for Non‑U.S. Citizens page for acceptable immigration statuses.

This program is administered by ORAU through its contract with the U.S. Department of Energy. Participants are not employees of FDA, DOE, or ORAU and receive no employment‑related benefits. Proof of health insurance is required. A successful background investigation by the Office of Personnel Management is required; OPM can conduct this investigation only for individuals who have resided in the U.S. for a total of at least three of the past five years.

If an ORISE Fellow, spouse, or minor children report a Significantly Regulated Organization (SRO) or prohibited investment fund interest, and the individual does not voluntarily divest, the individual is not placed  additional requirements, see FDA Ethics for Non‑employee Scientists.

Participants must read and sign the FDA Education and Training Agreement within 30 days of start date. Topics include:

• Non‑employee nature of the ORISE appointment
• Prohibition on ORISE Fellows performing inherently…